Google Search

Search

Already a Member ?

Pharmaceutical, Drugs, Fine Chemicals, Bulk Drug Intermediates, Pharmaceutical Drugs, Pharma Drug Ingredients Intermediates, Drug Intermediates, Speciality Chemicals, Raw Materials, Fine and Specialty Chemicals Intermediates, Pharmaceutical Bulk Drugs

Indian drugs and pharmaceutical industry has advanced perceptibly and is getting ready  for the new patent regime and  to withstand global competition, which is expected to be unleashed by new winds of liberalisation - a new era of liberalisation - much different from what was ushered in since the conclusion of the Uruguay Round and the establishment of the World Trade Organisation.

The industry has been expanding at annual rates ranging between 8 to 10% (against global growth rate of 6%).  According to a study  by McKinsey, Vision 2010, the domestic pharmaceutical industry could attain a size of  $25 billion (Rs 1200 billion) by 2010 by focusing on two areas: first, innovation-led research, development and new drug discoveries; and second, information technology-led remote sales and marketing.  The market for bulk drugs and formulations had increased from about Rs 103  billion in 1990-91 to an estimated Rs 435  billion at the end of 2003-04.  The prices of Indian essential drugs are among the lowest in the world. Apart from strides made by the industry in the last half-a-century, lower production cost due to reverse engineering and low R&D outlays has been a major factor in keeping the prices under check.

The global pharmaceutical industry is estimated at $ 300 billion, not all representing cross-border trade.  India's measly share of $ 1.5 billion in global trade represents an untapped potential. Under the regime of economic liberalisation underway since early 1990s, the drugs and pharmaceutical sector witnessed initiatives at fresh investment in the sector. Nearly 1735 investment proposals of the order of around Rs 166  billion were initiated. The foreign collaboration proposals approved numbered around 425 with a foreign direct investment  (FDI) component of over Rs 25 billion. The pharmaceuticals have figured high on the export front. In 2001-02,  the sector was  estimated to have registered a growth of 17.6% at around Rs 20.3 billion.

In the wake of economic liberalisation, many a  overseas players  returned or contemplated returning to India. These include Ivox Corp (USA),  Taro Pharmaceuticals (Israel) and Merck (USA). These are out either to set shop or looking for acquisitions in India. Hexal AG of Germany has established a liaison office in India. MILLIONCs like Rocha, Bayer, Aventis and Chiron are making India a regional hub for bulk drugs. 

The Export Import Bank of India (Exim Bank) had  doubled its corpus for the pharmaceutical industry to Rs 2 billion as a result of increased activity in the industry, especially in the external sector. The fund is used for the development and commercialisation of the new products and applications, significant improvement in the existing design of  products, setting up and expansion of pilot plants, research studies for obtaining regulatory approvals, cost of filing and managing international patent and R&D Centres.

It needs, however, to be recognised that the presence  of small scale manufacturers has resulted, on the one hand,  in a highly fragmented industry, and on the other, it has made it possible to supply a near 100,000 drugs including vitamins, antibiotics, antibacterials, cardio-vascular and other essential drugs. These account for nearly 37% of the market.  While each of about 80% of the manufacturers has annual sales below a billion rupees, top ten companies are known to control over 30% of the market. At present there are more than 20,000 players in the country.

The major players are: Alembic Chem, Aurobindo Pharma, Cipla, Dr. Reddy's, FDC, IPCA Labs, Jagsonpal Pharma, J.B. Chemicals, Kopran, Lupin Labs, Lyka Labs, Morepan Labs, Nicholas Piramal, Ranbaxy Labs, Sun Pharma, Themis Medicare, GlaxoSmithkline, Astrazeneca, Aventis, E-Merck, Torrent Pharma, TTK Healthcare, Unichem Labs,  Wockhardt  and  Zandu Pharma.  Until recently, only a few of the Indian companies had gone into any serious R&D activity. Much of the effort was directed to affordable analogue research. The R&D level in the country is low with even well-placed pharma companies spending less than 2% of turnover on R&D. MILLIONCs are known to contribute as much as 10% or more of their turnover to R&D.  While India is very strong in process chemistry, biology and applied bio-chemistry, initiatives at all levels - government, academia, private sector - involving heavy financial outlays, are called for.

Ayurveda continues to remain a preferred system of medicine for a vast segment of population in the country. The country has over 400,000 registered practitioners of the Indian system of medicine. Around 170 institutes properly affiliated to various universities impart under- or post-graduate courses each year. These institutes churn out some 5,500 fresh practitioners. The practitioners are supported by 12,000 dispensaries and 2,100 beds available for ayurveda treatment countrywide. The emerging biotechnology sector has already taken by storm and is offering sops to states to make these as the thriving ground for the highly potential segment in medicare.

We can provide you detailed project reports on the following topics. Please select the projects of your interests.

Each detailed project reports cover all the aspects of business, from analysing the market, confirming availability of various necessities such as plant & machinery, raw materials to forecasting the financial requirements. The scope of the report includes assessing market potential, negotiating with collaborators, investment decision making, corporate diversification planning etc. in a very planned manner by formulating detailed manufacturing techniques and forecasting financial aspects by estimating the cost of raw material, formulating the cash flow statement, projecting the balance sheet etc.

We also offer self-contained Pre-Investment and Pre-Feasibility Studies, Market Surveys and Studies, Preparation of Techno-Economic Feasibility Reports, Identification and Selection of Plant and Machinery, Manufacturing Process and or Equipment required, General Guidance, Technical and Commercial Counseling for setting up new industrial projects on the following topics.

Many of the engineers, project consultant & industrial consultancy firms in India and worldwide use our project reports as one of the input in doing their analysis.

We can modify the project capacity and project cost as per your requirement.
We can also prepare project report on any subject as per your requirement.

Page 14 of 21 | Total 201 projects in this category
« Previous   Page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 .... 20 21   Next »

Add multiple items to inquiry
Select the items and then press Add to inquiry button

Select all | Clear all Sort by

Bitter Gourd (Karela) Powder - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue

Karela is a vegetable which is grown in every part of India. Karela is especially grown in India in from April to August. In the session it is abundantly available. It is generally used as vegetable throughout India. It has also good medicinal value. It is generally bitter in taste. Karela powder is now special product which can be produced by spray drying process. Bitter gourd fruit is a good source of carbohydrates, proteins, vitamins, and minerals and have the highest nutritive value among cucurbits. The vitamin C content of Chinese bitter gourd varies significantly. Bitter gourd has been used for centuries in the ancient traditional medicine of India, China, Africa, and Latin America. Bitter gourd extracts possess antioxidant, antimicrobial, antiviral, antihepatotoxic and antiulcerogenic properties while also having the ability to lower blood sugar. These medical activities are attributed to an array of biologically active plant chemicals, including triterpenes, pisteins and steroids. Uses of Karela Powder • It can be used in the preparation of concentrated vegetable soup. • It can be used for the preparation herbal base medicine. • It can be used also in the preparation of cosmetics powder. As bitter gourd powder finds its major application in ayurvedic medicine, it would be suffice to gauge the demand for ayurvedic medicine. Ayurvedic medicines are produced by several thousand companies in India, but most of them are quite small, including numerous neighborhood pharmacies that compound ingredients to make their own remedies. It is estimated that the total value of products from the entire Ayurvedic production in India is on the order of one billion dollars (U.S.). The industry has been dominated by less than a dozen major companies for decades, joined recently by a few others that have followed their lead, so that there are today 30 companies doing a million dollars or more per year in business to meet the growing demand for Ayurvedic medicine. So any new entrants can venture in to this industry.
Plant capacity: 500 Kgs. / DayPlant & machinery: Rs. 97 Lakhs
Working capital: -T.C.I: Cost of Project : Rs. 236 Lakhs
Return: 24.00%Break even: 56.00%
Add to Inquiry Add to Inquiry Basket

Ayurvedic Medicines (Chyawanprash, Cough Syrup Herbal, Ayurvedic Hair Oil, Jawahar Mohra & Mukta Shukti Tablets) - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process

Man has always been keen to keep himself free from all miseries. It has been a constant endeavor to discover better ways to prevent and cure human disease. Human history is full of examples of foods developed for one or the other health benefit. Greeks used garlic in the first Olympic Games as they considered it as a performance-enhancing drug. Egyptians used honey to heal wounds. In India, the use of various herbs in daily diet for prevention and treatment is well known for ages. Cultural beliefs, experiences and availability of various herbs in India has made herbal preparations a part of Indian daily food supplements. The use of functional foods and nutraceuticals can be traced back to ancient Indian system of medicine. Ayurveda, a 5000 year old medical science. The classic texts of Ayurveda are full of references of the effects of food in various health conditions. Ayurveda clearly defines the use of food products for improving quality of life and general rejuvenation. Medicinal plants offer alternative remedies with tremensdous opportunities to generate income, employment andforeign exchange for developing countries. Many traditional healing herbs and their parts have been shown to have medicinal value and can be used to prevent, alleviate or cure several human diseases. India is one of the leading countries in Asia in terms of the wealth of traditional knowledge systems related to herbal medicine and employs a large number of plant species which includes Ayurveda (2000 species), Siddha (1121 species), Unani (751 species) and Tibetan (337 species). Today, ayurveda is an officially recognised system of medicine in India. Globally, the World Health Organization (WHO) recognises it as Traditional Medicine (TRM). It is estimated that the total market size of the Indian ayurvedic market size is Rs 8000 crore and it is growing substantially between 10-15 percent, with the same growth rate targeted for the next 10 years. Thus, due to demand it is a good project for entrepreneurs to invest.
Plant capacity: Chyawanprash: 500.0 Kgs/Day•Cough Syrup (Herbal): 200.0 Kgs/Day•Ayurvedic Hair Oil: 200.0 Kgs/Day•Jawahar Mohra Tablets :1.0 Kgs/Day•Mukta Shukti Tablets: 1.0 Kgs/DayPlant & machinery: Rs 69 Lakhs
Working capital: -T.C.I: Cost of Project : Rs 474 Lakhs
Return: 24.00%Break even: 57.00%
Add to Inquiry Add to Inquiry Basket

BLOOD BAGS - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue, Plant Economics

Blood bag is a disposable bio-medical device used for collection, storage, transportation and transfusion of human blood and blood components. The system consists of a single or multiple bag connected with tubings, needle, needle cover, clamp etc. The Blood Bags are made of plastic-material, which are compatible with blood. The introduction of flexible PVC bags for the storage of blood and its components totally replaced the use of glass bottles because of its numerous advantages. Blood bags enable better separation of blood components in a more sterile manner and safer transfusion of components. This has led to increasingly wider use of blood component therapy than whole blood use, thus enabling more effective use of the scarce donor blood that is available. Blood Bags can successfully replace the use of glass bottles for collection storage, transportation and transfusion of blood and blood components since bottles require exhaustive cleaning, rinsing and autoclaving procedures and there are chances of breakage at any stage. Further, use of disposable bags eliminates the possibility of any contamination. Blood bags contain an anticoagulant solution and a red blood cell preservative solution, and are used in blood banks which both collect donor blood and separate blood components. Blood bags are made from imported, medical grade PVC granules & sheets in Class 10000 Clean room environments. Increase in the healthcare facilities will further act as a driver for the growth of medical devices sector in India. The blood bag market is expected to grow further in the coming years owing to continuous developments and rising demand for better blood collection technology. As a whole it is a good project for new entrepreneurs to invest.
Plant capacity: 30000 Nos./DayPlant & machinery: Rs 426 Lakhs
Working capital: -T.C.I: Cost of Project: Rs 1465 Lakhs
Return: 27.00%Break even: 48.00%
Add to Inquiry Add to Inquiry Basket

Pharmaceutical Unit (Tablet, Capsules & Syrup) - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities

The Indian pharmaceutical sector has come a long way, being almost non-existent before 1970 to a prominent provider of healthcare products, meeting almost 95 per cent of the country's pharmaceuticals needs. The Industry today is in the front rank of India’s science-based industries with wide ranging capabilities in the complex field of drug manufacture and technology. It ranks very high in the third world, in terms of technology, quality and range of medicines manufactured. From simple headache pills to sophisticated antibiotics and complex cardiac compounds, almost every type of medicine is now made indigenously. Globally, the Indian pharmaceutical industry is ranked third largest in volume terms and 10th largest in value terms. The sector is highly knowledge-based and its steady growth is positively affecting the Indian economy. The organised nature of the Indian pharmaceutical industry is attracting several companies that are finding it viable to increase their operations in the country. The Indian pharmaceutical industry also needs to take advantage of the recent advances in biotechnology and information technology. The future of the industry will be determined by how well it markets its products to several regions and distributes risks, its forward and backward integration capabilities, its R&D, its consolidation through mergers and acquisitions, co-marketing and licensing agreements. Thus, due to demand it is a good project for entrepreneurs to invest. Few Indian Major Players are as under • A Tosh & Sons (India) Ltd. • Aarti Industries Ltd. • Agio Pharmaceuticals Ltd. • Alintosch Pharmaceuticals Ltd. • Anil Bioplus Ltd. • Anil Starch Products Ltd. • Astrix Laboratories Ltd. • B A & Brothers (Eastern) Ltd. • Caldern Pharmaceuticals Ltd. • Expicor Pharma Pvt. Ltd. • Fem Care Pharma Ltd. • German Remedies Ltd. • Hiran Orgochem Ltd. • Kedia Chemicals Inds. Ltd. • Kunshan Rotam Reddy Pharmaceutical Co. Ltd. • Larite Industries Ltd. • Lyka Labs Ltd. • Max Healthcare Institute Ltd. • Midas Pharmasec Ltd. • N G L Fine-Chem Ltd. • Norris Medicines Ltd. • Sanofi India Ltd. • Sayaji Industries Ltd. • Stellar Exports Ltd. • Suyash Laboratories Ltd. • United Breweries (Holdings) Ltd. • Vellanova Pharmaceuticals Ltd. • Vera Pharma Ltd. • Vivo Bio Tech Ltd. • Winmac Laboratories Ltd. • Yogi Pharmacy Ltd.
Plant capacity: Tablets: 500,000 Nos./Day,Capsules:500,000 Nos./Day,Syrup (100 ml Size):12,500 Nos./DayPlant & machinery: Rs 178 Lakhs
Working capital: -T.C.I: Cost of Project: Rs 6342 Lakhs
Return: 31.00%Break even: 32.00%
Add to Inquiry Add to Inquiry Basket

Pharmaceutical Unit (Tablet And Capsules) - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities

The Indian pharmaceutical sector has come a long way, being almost non-existent before 1970 to a prominent provider of healthcare products, meeting almost 95 per cent of the country's pharmaceuticals needs. The Industry today is in the front rank of India’s science-based industries with wide ranging capabilities in the complex field of drug manufacture and technology. It ranks very high in the third world, in terms of technology, quality and range of medicines manufactured. From simple headache pills to sophisticated antibiotics and complex cardiac compounds, almost every type of medicine is now made indigenously. Globally, the Indian pharmaceutical industry is ranked third largest in volume terms and 10th largest in value terms. The sector is highly knowledge-based and its steady growth is positively affecting the Indian economy. The organised nature of the Indian pharmaceutical industry is attracting several companies that are finding it viable to increase their operations in the country. The Indian pharmaceutical industry also needs to take advantage of the recent advances in biotechnology and information technology. The future of the industry will be determined by how well it markets its products to several regions and distributes risks, its forward and backward integration capabilities, its R&D, its consolidation through mergers and acquisitions, co-marketing and licensing agreements. Thus, due to demand it is a good project for entrepreneurs to invest. Few Indian Major Players are as under • A Tosh & Sons (India) Ltd. • Aarti Industries Ltd. • Agio Pharmaceuticals Ltd. • Alintosch Pharmaceuticals Ltd. • Anil Bioplus Ltd. • Anil Starch Products Ltd. • Astrix Laboratories Ltd. • B A & Brothers (Eastern) Ltd. • Caldern Pharmaceuticals Ltd. • Expicor Pharma Pvt. Ltd. • Fem Care Pharma Ltd. • German Remedies Ltd. • Hiran Orgochem Ltd. • Kedia Chemicals Inds. Ltd. • Kunshan Rotam Reddy Pharmaceutical Co. Ltd. • Larite Industries Ltd. • Lyka Labs Ltd. • Max Healthcare Institute Ltd. • Midas Pharmasec Ltd. • N G L Fine-Chem Ltd. • Norris Medicines Ltd. • Sanofi India Ltd. • Sayaji Industries Ltd. • Stellar Exports Ltd. • Suyash Laboratories Ltd. • United Breweries (Holdings) Ltd. • Vellanova Pharmaceuticals Ltd. • Vera Pharma Ltd. • Vivo Bio Tech Ltd. • Winmac Laboratories Ltd. • Yogi Pharmacy Ltd.p
Plant capacity: Tablets:100,000 Strips./Day •Capsules:100,000 Strips./DayPlant & machinery: Rs 271 Lakhs
Working capital: -T.C.I: Cost of Project: Rs 1866 Lakhs
Return: 32.00%Break even: 38.00%
Add to Inquiry Add to Inquiry Basket

Pharmaceutical Unit (Tablet And Capsules) - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities

The Indian pharmaceutical sector has come a long way, being almost non-existent before 1970 to a prominent provider of healthcare products, meeting almost 95 per cent of the country's pharmaceuticals needs. The Industry today is in the front rank of India’s science-based industries with wide ranging capabilities in the complex field of drug manufacture and technology. It ranks very high in the third world, in terms of technology, quality and range of medicines manufactured. From simple headache pills to sophisticated antibiotics and complex cardiac compounds, almost every type of medicine is now made indigenously. Globally, the Indian pharmaceutical industry is ranked third largest in volume terms and 10th largest in value terms. The sector is highly knowledge-based and its steady growth is positively affecting the Indian economy. The organised nature of the Indian pharmaceutical industry is attracting several companies that are finding it viable to increase their operations in the country. The Indian pharmaceutical industry also needs to take advantage of the recent advances in biotechnology and information technology. The future of the industry will be determined by how well it markets its products to several regions and distributes risks, its forward and backward integration capabilities, its R&D, its consolidation through mergers and acquisitions, co-marketing and licensing agreements. Thus, due to demand it is a good project for entrepreneurs to invest.
Plant capacity: Tablets:10,000 Strips/Day •Capsules:10,000 Strips/DayPlant & machinery: Rs 262 Lakhs
Working capital: -T.C.I: Cost of Project:Rs 554 Lakhs
Return: 28.00%Break even: 54.00%
Add to Inquiry Add to Inquiry Basket

IV Fluid and Dialysis Solution - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue

Intravenous therapy IV therapy is the infusion of liquid substances directly into a vein. Intravenous simply means "within vein". Therapies administered intravenously are often called specialty pharmaceuticals. Compared with other routes of administration, the intravenous route is the fastest way to deliver fluids and medications throughout the body. The bioavailability of the medication is 100% in IV therapy. The majority of an IV solution is sterile water. Chemically, water is referred to as a “solvent.” A solvent is a substance that dissolves other materials called “solutes.” Within IV solutions, the solutes can be molecules called electrolytes (charged particles such as sodium, potassium, and chloride) and/or other larger compounds such as proteins or molecules. Patient needs IV fluid therapy for maintenance (to supply daily needs), replacement (to replace deficit and on-going losses) and resuscitation (to correct an intravascular or extracellular deficit). Therefore, it is a good project for entrepreneurs to invest. Few Indian Major Players are as under • Ahlcon Parenterals (India) Ltd. • Amanta Healthcare Ltd. • Goa Formulations Ltd. • Kokad Pharmaceutical Laboratories Ltd. • Parenteral Surgicals Ltd. • Punjab Formulations Ltd. • Senbo Industries Ltd. •Shree Krishna Keshav Laboratories Ltd. •Span Medicals Ltd. •Wockhardt Health Care Ltd.
Plant capacity: IV Fluid NS5 (500 ml Size):8,000 Bottles/Day •IV Fluid DNS (500 ml Size): 8,000 Bottles/Day •IV Fluid RL (500 ml Size): 8,000 Bottles/Day •IV Fluid D5 (500 ml Size): 8,000 Bottles/Day •IV Fluid D10 (500 ml Size): 4,000 Bottles/Day •Dialysis Solution (1000Plant & machinery: Rs 315 Lakhs
Working capital: -T.C.I: Cost of Project :Rs 1151 Lakhs
Return: 28.41%Break even: 43.11%
Add to Inquiry Add to Inquiry Basket

Pharmaceutical Unit (Tablets, Syrup, Capsules & Ointment) - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Plant Layout

The pharmaceutical industry develops, produces, and markets drugs or pharmaceuticals licensed for use as medications. Pharmaceutical companies are allowed to deal in generic and/or brand medications and medical devices. They are subject to a variety of laws and regulations regarding the patenting, testing and ensuring safety and efficacy and marketing of drugs. The pharmaceutical industry also needs to take advantage of the recent advances in biotechnology and information technology. The future of the industry will be determined by how well it markets its products to several regions and distributes risks, its forward and backward integration capabilities, its R&D, its consolidation through mergers and acquisitions, co-marketing and licensing agreements. The three major segments - domestic formulations, formulation exports and bulk drug exports - have traditionally been the backbone of the pharmaceutical industry. Tablets are solid unit dosage form of medicaments with or without suitable diluents and prepared either by molding or compression. They are solid, flat or biconvex disc in shape. They vary greatly in shape, size and weight which depend upon amount of medicament used and mode of administration. They also vary in hardness, thickness, and disintegration and dissolution characteristics and in other aspects depending upon their intended use and method of manufacture. Tablets are the most widely used solid dosage form of medicament. Because of their advantages their popularity is continuously increasing day by day. Thus, due to demand it is a good project for entrepreneurs to invest. Capacity • Metronidazole Compressed Tablets: 75,000 Nos/Day • Paracetamol Compressed Tablets: 75,000 Nos/Day • Erythromycin Compressed Tablets: 75,000 Nos/Day • Sulfamethoxazole and Trimethoprim Compressed Tablets: 75,000 Nos/Day • Metformin Film Coated Tablets: 83,333 Nos/Day • Amlodipine Besylate Sugar Coated Tablets: 33,333Nos/Day • Piroxicam Capsules: 3,00,000 Nos/Day • Loperamide Hydrochloride Capsules: 3,00,000 Nos/Day • Metronidazole Suspension : 66,666 Nos/Day • Paracetamol Suspension : 66,666 Nos/Day • Sulfamethoxazole and Trimethoprim Suspension : 66,666 Nos/Day • Tolu Balsm Cough Syrup : 66,666 Nos/Day • Vitamin a and Vitamin D3 Syrup: 66,666 Nos/Day • Ointment: 20,000 Nos/Day
Plant capacity: -Plant & machinery: Rs 840 Lakhs
Working capital: -T.C.I: Cost of Project :Rs 136219 Lakhs
Return: 36.84%Break even: 29.39%
Add to Inquiry Add to Inquiry Basket

Petroleum Jelly - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue, Plant Layout

Petroleum jelly or petrolatum was discovered as a paraffin-like material coating oil rigs. Since then, it has been used in various ointments and as a lubricant. Petroleum jelly is mixture of mineral waxes and oils that together lock moisture in skin, moisturizing it to repair and relieve dryness. They are stabilized in such fashion that the oil appears to form the internal phase, whereas the wax compound forms the external phase. Petroleum jelly is made by the waxy petroleum material that formed on oil rigs and distilling it. The lighter and thinner oil-based products make up petroleum jelly, also known as white petrolatum or simply as petrolatum. Robert Chesebrough is the chemist who devised and patented this process. Basically, the crude material undergoes vacuum distillation. The still residue is then filtered through bone char to yield petroleum jelly. At room temperature, petroleum jelly is an odourless semi-solid which consists of a mixture of hydrocarbons. Petroleum jelly has fibrous or grease like structure and also possess discreet drop point and penetration value . Petroleum jelly may be considered as microcrystalline wax which has absorbed the oil, resulting in an amorphous jelly like mass. It is mostly available in two colours namely white and yellow. Petroleum jelly is hugely versatile, and it’s used all over the world to protect and heal dry skin, from dry, cracked hands to hard skin on heels, as well as for beauty purposes, like softening the lips or highlighting the cheekbones. Application sector Petroleum jelly is an ingredient in many cosmetics and lotions. Originally it was marketed as a burn ointment. Petroleum jelly also may be applied to dry or chapped skin to seal in moisture. A variation known as red veterinary petroleum confers some protection against UV (ultraviolet) exposure and has been used as a sunscreen. • Pharmaceuticals/ Cosmetics industry • Jelly filled cable • Leather industry • Rubber industry • Other miscellaneous application including rust prevention etc. Petroleum jelly white / yellow IP uses are as follows: • Skin ointment / Skin cream • Hair Vaseline • Pain balm • Cold cream and cosmetic preparations • Ophthalmic ointment • Vaporub Ointment Indian demand: Various Cosmetics and pharmaceuticals are used by the large number of people in general for wounds, cuts, burns, skin diseases. In today’s business word, more and cosmetics industries are coming up and thereby increasing the demand for the raw materials like petroleum jelly. Hence it can be assumed that the petroleum jelly is having very good market potential in view of development of cosmetic & pharmaceutical industry in India. Present demand for petroleum jelly including export demand is around 70000 metric tonne per annum Growth rate in demand for 2021: 7% per annum Indian producers include the following: • Eastern Petroleum (P) Ltd., Maharashtra • Mahatha Petroleum (P) Ltd., Tamilnadu • Panama Petrochem Gujarat • Gandhar Oil Refinery Maharashtra • Asian Oil Company Maharashtra • Bhakti Petrochem P Ltd., Maharashtra • Unicorn Petroleum Inds P Ltd., Maharashtra • Kim Chemicals Ltd , Maharashtra Global petroleum jelly market Global supplies of microcrystalline wax and petroleum jelly continue to shrink due to the reduction in API Group I and specifically base oil Group I production capacity. On the other hand, demand for microcrystalline wax and petroleum jelly continues to be strong, helped by the recovery in many parts of the world. The resultant rise in prices has motivated wax de oilers, blenders, specialty wax producers to seek alternatives. The interplay of supply and demand drivers and the penetration of alternate materials will set the future direction of this product market. While natural and organic products account for a small percentage of the total skin care market, their share is growing faster than the general market.
Plant capacity: -Plant & machinery: -
Working capital: -T.C.I: -
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

Paracetamol- Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue, Plant Economics

Paracetamol, also known as acetaminophen or APAP, is a medication used to treat pain and fever. It is typically used for mild to moderate pain. It is often sold in combination with other ingredients such as in many cold medications. In combination with opioid pain medication, paracetamol is used for more severe pain such as cancer pain and after surgery. It is typically used either by mouth or rectally but is also available intravenously. Effects last between two and four hours. Paracetamol lacks anti-inflammatory action in rheumatic disorders. However, it is less toxic than the Aspirin and does not produce anemia and liver damage, which sometimes result from the continued use of acetanilide andacetophenetidin. It is also an important intermediate in the manufacture of other pharmaceuticals like theantimalarial amodiaquine. The pharmaceutical industry in India ranks 3rd in the world terms of volume and 14th in terms of value. 20% of global exports in generics, making it the largest provider of generic medicines globally. USD 45 Billion in revenue by 2020, revenue of USD 55 billion by 2020 as base case, and can grow to USD 70 billion in a aggressive case scenario. USD 26.1 Billion in generics by 2016. USD 200 Billion to be spent on infrastructure by 2024. Global pharma companies are increasingly exploring low cost option to outsource research and manufacturing, because of emerging slow-down in patented drug sales and high cost of R&D.Thus, as an entrepreneur this project offers an exciting opportunity to you. Few Indian Major Players are as under • Ranbaxy (Daichi) • Dr. Reddy's Labs • Cipla • Lupin • AurobindoPharma • Sun Pharma • GlaxoSmithkline • CadilaPharma • Nicholas Piramal • WokhardtLifesciences
Plant capacity: 300,000 Kgs/annumPlant & machinery: 98 lakhs
Working capital: -T.C.I: Cost of Project: 495 lakhs
Return: 25.00%Break even: 40.00%
Add to Inquiry Add to Inquiry Basket

Information
  • One Lac / Lakh / Lakhs is equivalent to one hundred thousand (100,000)
  • One Crore is equivalent to ten million (10,000,000)
  • T.C.I is Total Capital Investment
  • We can modify the project capacity and project cost as per your requirement.
  • We can also prepare project report on any subject as per your requirement.
  • Caution: The project's cost, capacity and return are subject to change without any notice. Future projects may have different values of project cost, capacity or return.

Add multiple items to inquiry
Select the items and then press Add to inquiry button

Page 14 of 21 | Total 201 projects in this category
« Previous   Page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 .... 20 21   Next »

About NIIR PROJECT CONSULTANCY SERVICES

Hide »

NIIR PROJECT CONSULTANCY SERVICES (NPCS) is a reliable name in the industrial world for offering integrated technical consultancy services. NPCS is manned by engineers, planners, specialists, financial experts, economic analysts and design specialists with extensive experience in the related industries.

Our various services are: Detailed Project Report, Business Plan for Manufacturing Plant, Start-up Ideas, Business Ideas for Entrepreneurs, Start up Business Opportunities, entrepreneurship projects, Successful Business Plan, Industry Trends, Market Research, Manufacturing Process, Machinery, Raw Materials, project report, Cost and Revenue, Pre-feasibility study for Profitable Manufacturing Business, Project Identification, Project Feasibility and Market Study, Identification of Profitable Industrial Project Opportunities, Business Opportunities, Investment Opportunities for Most Profitable Business in India, Manufacturing Business Ideas, Preparation of Project Profile, Pre-Investment and Pre-Feasibility Study, Market Research Study, Preparation of Techno-Economic Feasibility Report, Identification and Section of Plant, Process, Equipment, General Guidance, Startup Help, Technical and Commercial Counseling for setting up new industrial project and Most Profitable Small Scale Business.

NPCS also publishes varies process technology, technical, reference, self employment and startup books, directory, business and industry database, bankable detailed project report, market research report on various industries, small scale industry and profit making business. Besides being used by manufacturers, industrialists and entrepreneurs, our publications are also used by professionals including project engineers, information services bureau, consultants and project consultancy firms as one of the input in their research.

^ Top